Inhibikase TherapeuticsIKT
13F holders, Q3 2025 (September 30)54holders +6
8new positions
2sold out
1famous investor
$1.62avg. 13F price*
At the end of Q3 2025, 54 institutions reported holding Inhibikase Therapeutics Inc. (IKT) in their 13F filings, up 6 from Q2 2025. 8 opened new positions and 2 sold out. The largest holders were Sands Capital Alternatives, LLC ($17.7M), Soleus Capital Management, L.P. ($10.2M) and Fairmount Funds Management LLC ($9.9M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Inhibikase Therapeutics Inc.
- CUSIP
- 45719W205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $299K |
| Exits | 2 | $63K |
All 13F filers, Q2 2025 → Q3 2025: 1,013,906 shares bought and 561,496 shares sold, net +452,410 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 54 holders
| Sands Capital Alternatives, LLC | 3.89% | No change | 10,950,000 | $17.7M |
| Soleus Capital Management, L.P. | 0.55% | No change | 6,325,000 | $10.2M |
| Fairmount Funds Management LLC | 0.89% | No change | 6,125,000 | $9.9M |
| Perceptive Advisors LLC | 0.26% | Reduce -0.2% | 5,421,568 | $8.8M |
| Commodore Capital LP | 0.43% | No change | 5,397,488 | $8.7M |
| ADAR1 Capital Management, LLC | 0.85% | Add +2.5% | 5,247,603 | $8.5M |
| Vanguard Group Inc. | 0.00% | Add +1.5% | 3,273,339 | $5.3M |
| BlackRock, Inc. | 0.00% | Add +12.7% | 3,075,186 | $5.0M |
| Blackstone Inc. | 0.02% | No change | 2,638,276 | $4.3M |
| Nantahala Capital Management, LLC | 0.22% | No change | 2,190,000 | $3.5M |
| Geode Capital Management, LLC | 0.00% | Add +4.3% | 1,112,574 | $1.8M |
| Stonepine Capital Management, LLC | 0.97% | Add +0.2% | 735,019 | $1.2M |
| State Street Corp. | 0.00% | Add +27.6% | 507,749 | $823K |
| Northern Trust Corp. | 0.00% | Reduce -4.7% | 374,336 | $606K |
| Blair William & Co. | 0.00% | Reduce -2.5% | 152,953 | $248K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 152,298 | $247K |
| Bank of New York Mellon Corp | 0.00% | Add +4.7% | 138,667 | $225K |
| UBS Group AG | 0.00% | Add +252.4% | 136,280 | $221K |
| FMR LLC | 0.00% | Reduce -26.7% | 105,770 | $171K |
| Barclays PLC | 0.00% | Reduce -22.4% | 85,578 | $139K |
| Deutsche Bank AG | 0.00% | New | 80,496 | $130K |
| Nuveen, LLC | 0.00% | No change | 78,659 | $127K |
| Citadel Advisors | 0.00% | New | 71,670 | $116K |
| Rhumbline Advisers | 0.00% | Reduce -1.7% | 57,551 | $93K |
| Morgan Stanley | 0.00% | Reduce -43.8% | 56,019 | $91K |
| JPMorgan Chase & Co. | 0.00% | Add +74.7% | 49,937 | $81K |
| New York State Common Retirement Fund | 0.00% | Reduce -21.1% | 47,900 | $78K |
| Wells Fargo & Company | 0.00% | Add +19.4% | 45,745 | $74K |
| Susquehanna International Group, LLP | 0.00% | Reduce -88.1% | 45,605 | $74K |
| Invesco Ltd. | 0.00% | Add +7.6% | 33,034 | $54K |
| Intech Investment Management LLC | 0.00% | Add +1.6% | 31,918 | $52K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 30,606 | $50K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -15.3% | 27,963 | $45K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | No change | 17,638 | $29K |
| Bank of America Corp. | 0.00% | Reduce -11.0% | 17,102 | $28K |
| Caxton Corp. | 0.12% | No change | 16,393 | $27K |
| BNP Paribas Financial Markets | 0.00% | Add +70.3% | 15,640 | $25K |
| Virtu Financial LLC | 0.00% | New | 13,446 | $22K |
| Voya Investment Management LLC | 0.00% | Reduce -29.9% | 13,146 | $21K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,735 | $17K |
| Focus Partners Advisor Solutions, LLC | 0.00% | No change | 10,708 | $17K |
| ProShare Advisors LLC | 0.00% | Reduce -16.6% | 10,341 | $17K |
| Russell Investments Group, Ltd. | 0.00% | New | 7,702 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +6946.0% | 7,046 | $11K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 6,174 | $10K |
| Legal & General Group Plc | 0.00% | No change | 5,504 | $9K |
| Sterling Capital Management LLC | 0.00% | Add +154.3% | 3,827 | $6K |
| California State Teachers Retirement System | 0.00% | Add +0.1% | 3,776 | $6K |
| Amalgamated Bank | 0.00% | No change | 2,065 | $3K |
| Citigroup Inc. | 0.00% | Reduce -95.6% | 902 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -85.5% | 663 | $1K |
| PNC Financial Services Group, Inc. | 0.00% | New | 90 | $146 |
| Arax Advisory Partners | 0.00% | New | 86 | $139 |
| Cwm, LLC | 0.00% | New | 19 | $0 |
"% of holder's portfolio" is IKT's weight in each manager's 13F, not the share of Inhibikase Therapeutics Inc. the manager owns.